News and Announcements
Anteo Diagnostics Ltd Acquires DIAsource ImmunoAssays SA & Other Highlights
- Published July 06, 2016 11:19AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
6th July 2016, Anteo Diagnostics
Revenues of €14.171M in CY15 growing at greater than 10% per annum
DIAsource provides a strong platform
Other highlights from the past 12 months include:
- Filed two new patents in battery (energy) space
- Appointed new distributors, including Sigma Aldrich
- Successful trip to Tokyo Battery Expo yielded strong interest with global battery companies
- Appointed Dr Jef Vangenechten Global CEO and Mr Rolf Sickman to the Board
- Collaborating with Cook Medical on medical devices
- Awarded funding for the development of a new rapid blood test for heart attacks in partnership with Atomo Diagnostics
ABOUT ANTEO DIAGNOSTICS
Anteo Diagnostics (ASX: ADO) is a global medical technology company, developing and commercialising products for sale into the lifesciences, in-vitro diagnostics, point of care, medical devices and bioseparations markets.